Sentinel Lymph Node Biopsy and Staging of Melanoma using Lymphoscintigraphy and Gamma-probe

Korean Journal of Dermatology

Volumn 41, Issue 12, 2003, Pages 1575-1582

  Kim, Hong Seok ^a   Song, Ki Hoon ^a   Sim, Seung Joo ^a   Kang, Do Young ^a   Kim, Ki Ho ^a  

^a Dong A University   (South Korea)

Author keywords

Intraoperative gamma probe; Lymphoscintigraphy; Malignant melanoma; Sentinel lymph node

Indexed keywords

AMERSCAN HEPATATE II; ANTIMONY TECHNETIUM SULFIDE TC 99M; NALGENE; SERUM ALBUMIN TC 99M; TECHNE; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER STAGING; CLINICAL ARTICLE; COLLOID; FEMALE; GAMMA RADIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; INTRAOPERATIVE PERIOD; KOREA; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

EID: 1442325344     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Johnson TM, Dolan OM, Hamilton TA, Lu MC, Swanson NA, Lowe L. Clinical and histological trends of melanoma. J Am Acad Dermatol 1998;38:681-686
2. Huang CL, Provost N, Marghoob AA, Kopf AW, Levin L, Bart RS. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma. J Am Acad Dermatol 1998;39:451-463
3. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ. et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:1-8
4. Kim CJ, Reintgen DS, Balch CM. The new melanoma staging system. Cancer Control 2002:9;9-15
5. Intenzo CM, Kim SM, Patel JI, Lin HC, Kairy JC. Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping. Radiographics 2002;22:491-502
6. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional modes in patients with melanoma of the trunk: a randomized trial. WHO melanoma programme. Lancet 1998;351:793-796
7. Chao C, McMasters KM. Update on the use of sentinel node biopsy in patients with melanoma: who and how. Curr Opin Oncol 2002;14:217-220
8. Sugranes G, Vidal-Sicart S, Piulachs J, Bombuy E, Pons F, Castel T, Rull R, Herranz R, Visa J. Gamma-detecting probe used intraoperatively to locate the sentinel lymph node in patients with malignant melanoma. Eur J Surg 2001;167:581-586
9. Hunt JL, Baloch ZW, Livolsi VA. Sentinel lymph node evaluation for tumor metastasis. Semin Diagn Pathol 2002;19:269-277
10. Creager AJ, Shiver SA, Shen P, Geisinger KR, Levine EA. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 2002;94:3016-3022
11. Reintgen DS. Regional nodal surgery for melanoma impacts recurrence rates and survival. Ann Surg Oncol 2000;7:80-81
12. Ramnath EM, Kamath D, Andrea B, Stall A, Kamath V, Cruse CW, Glass F. et al. Lymphatic mapping for melanoma: Long-term results of regional nodal sampling with radioguided surgery. Cancer Control 1997;4:483-490
13. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003;44:570-582
14. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399
15. Balch CM, Soong Sj, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ. et al. Efficacy of an elective regional lymph node dissection of 1 to 4mm thick melanomas for patient 60 years of age and younger. Ann Surgery 1996;224:255-263
16. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, Fenske N. et al. Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement. J Clin Oncol 2001;19:2851-2855
17. Bostick PJ, Giuliano AE. Vital dyes in sentinel node localization. Semin Nucl Med 2000;30:18-24
18. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe guided lymph node localization in malignant melanoma Surg Oncol 1993;2;303-308
19. Alex JC, Krag DN. Gamma probe guided localization of lymph nodes. Surg Oncol 1993;2:137-143
20. Tremlay F, Louffi A, Shibata H, Meterissian S. Sentinel lymph node biopsy for melanoma of the trunk and extremities: the McGill experience. Can J Surg 2001;44:428-431
21. 99mTc-labeled liposomes encapsulating blue dye for identification of the sentinel lymph node. J Nucl Med 2001;42:446-451
22. Thompson JF, Saw RP, Colman MH, Howman-Giles RB, Uren RF. Contralateral groin node metastasis from lower limb melanoma. Eur J Cancer 1997;33:976-977
23. Porter GA, Ross MI, Berman RS, Lee JE, Mansfield PF, Gershenwald JE. Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2000;7:256-261
24. Krag DN, Weaver DL. Pathological and molecular assessment of sentinel lymph nodes in solid tumors. Semin Oncol 2002;29:274-279
25. Vaggelli L, Castagnoli A, Borgognoni L, Urso C, Matteini M, Cesco P. Radioisotopic lymphatic mapping of the sentinel node in melanoma: Importance of immunohistochemistry. Tumori 2000;86:346-348
26. Eigtved A, Andersson AP, Dahlstøm K, Rabøl A, Jensen M, Holm S, Sørensen SS. et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med 2000;27:70-75
27. Prichard RS, Hill ADK, Skehan SJ, O'Higgins NJ. Positron emission tomography for staging and management of malignant melanoma. Br J Surg 2002;89:389-396
28. Otley CC, Zitelli JA. Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities. Dermatol Surg 2000;26:177-180
29. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, Temple WJ. et al. Efficacy of an elective regional lymph node dissection of 1- to 4-mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;24:255-263